Nova Pharmaceuticals
Pharmaceuticals
Founded in 2003 in Sydney Australia. New Zealand subsidiary set up in 2005. Largest supplier of generic & private label products in Australasia. Acquired by Marksans Pharma in 2005.

Overall

Owned IND
Rating D+
About the Ratings

Company Ownership

Nova Pharmaceuticals Australasia Pty Ltd
AUS
Marksans Pharma Ltd
owns 60% of Nova Pharmaceuticals Australasia Pty Ltd
IND
Pharmaceuticals
Acquired Nova Pharmaceuticals in 2005.

Company Assessment

(Last updated Apr 2025)
Nova Pharmaceuticals Australasia Pty Ltd
No assessment data currently available for Nova Pharmaceuticals Australasia Pty Ltd.
Marksans Pharma Ltd
Criticism
High ESG Risk
Sustainalytics, a top ESG research firm, evaluates environmental, social, and governance risks for over 16,000 companies. Its ESG Risk Rating reflects how much risk a company faces in its industry and how well it manages those risks. The final score includes both unmanaged and unmanageable risks, and companies are rated on a scale from negligible (0-10) to severe (40+). This company received an ESG Risk Rating of 38.2, placing it in the "high risk" category (retrieved April 2025).
> About the Icons

Company Details

Type:
Wholly-owned subsidiary
Founded:
2003

Contact Details

Address:
Suite 305, 10 Norbrik Drive, Bella Vista, NSW, 2153, Australia
Phone:
02 8090 7855
Website:
www.novapharm.com.au

Products / Brands

Nova Pharmaceuticals
Medix Medicinal Oils